Mitsubishi UFJ Asset Management
TNGX icon

Mitsubishi UFJ Asset Management’s Tango Therapeutics TNGX Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$252K Sell
8,064
-13,281
-62% -$328K ﹤0.01% 995
2026
Q1 		$447K Sell
21,345
-527
-2% -$7.33K ﹤0.01% 880
2025
Q4 		$195K Buy
+21,872
New +$188K ﹤0.01% 1024
2024
Q4 		– Sell
-25,934
Closed -$200K – 1609
2024
Q3 		$200K Sell
25,934
-2,446
-9% -$23.3K ﹤0.01% 964
2024
Q2 		$244K Buy
+28,380
New +$219K ﹤0.01% 941

Other funds holding TNGX

RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Paradigm Biocapital Advisors
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Mitsubishi UFJ Asset Management's TNGX Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management reduced its Tango Therapeutics (TNGX) stake by 62% in Q2 2026, selling an estimated $328K and leaving 8,064 shares worth $252K. The position accounts for ﹤0.01% of the portfolio, ranked #995.

Mitsubishi UFJ Asset Management first reported a position in TNGX in Q2 2024 and has held it in 5 quarters since. The position peaked at $447K in Q1 2026. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Mitsubishi UFJ Asset Management held 8,064 shares of Tango Therapeutics worth $252K as of Q2 2026.
  • Mitsubishi UFJ Asset Management sold 13,281 Tango Therapeutics shares in Q2 2026, an estimated $328K.
  • Tango Therapeutics made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #995 holding.
  • Mitsubishi UFJ Asset Management first reported a position in Tango Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • Mitsubishi UFJ Asset Management's Tango Therapeutics position peaked at $447K in Q1 2026.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.